Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1836564 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $5.06Day +2.02%1Y −33.5%Off 52W high −58.7%Vol (1Y) 72.7%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,290 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.1% of sh out |
| Days to cover6.1d |
| 13F net flow (QoQ)−0.74% |
| Top-10 13F concentration99.9% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)€174.7M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (EUR). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−42.6% |
| 1Y−33.5% |
| 3Y−66.4% |
| 5Y−82.0% |
| Since incept. (ann.)−28.8% |
Total return through 2026-07-28 · series begins 2021-06-01. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)72.7% |
| Ann. volatility (3Y)64.2% |
| Sharpe (1Y)−0.18 |
| Sharpe (3Y)−0.23 |
| Max drawdown (1Y)−60.8% |
| Max drawdown (3Y)−75.8% |
| Beta (3Y vs SPY)0.56 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 2.3M | $14M | 1.32% | +0.0% |
| NOVO HOLDINGS A/S | 1.1M | $7M | 0.61% | −54.1% |
| GENERAL AMERICAN INVESTORS CO INC | 354,361 | $2M | 0.20% | +0.0% |
| WELLS FARGO & COMPANY/MN | 78,029 | $487,681 | 0.04% | −36.8% |
| MORGAN STANLEY | 46,925 | $293,282 | 0.03% | +9.2% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 25,135 | $157,094 | 0.01% | +0.0% |
| HRT FINANCIAL LP | 20,847 | $130,000 | 0.01% | new |
| OLD MISSION CAPITAL LLC | 13,759 | $85,993 | 0.01% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
No reported quarters on file for VALN.
